APA (7th ed.) Citation

Bennani, N. N., Nowakowski, G., Rimsza, L. M., Adjei, A. A., Doyle, L., & Ansell, S. M. (2019). Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study. Blood, 134(Supplement_1), 4090. https://doi.org/10.1182/blood-2019-129104

Chicago Style (17th ed.) Citation

Bennani, N. Nora, Grzegorz Nowakowski, Lisa M. Rimsza, Alex A. Adjei, Laurence Doyle, and Stephen M. Ansell. "Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study." Blood 134, no. Supplement_1 (2019): 4090. https://doi.org/10.1182/blood-2019-129104.

MLA (9th ed.) Citation

Bennani, N. Nora, et al. "Copanlisib in Combination with Nivolumab in Subjects with Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Primary Mediastinal Large B-Cell Lymphoma: A Phase 2 Study." Blood, vol. 134, no. Supplement_1, 2019, p. 4090, https://doi.org/10.1182/blood-2019-129104.